News
LH
239.67
-0.21%
-0.50
Executive reshuffles: MFC, LYB, IDXX and TEX
Seeking Alpha · 21h ago
Ex-Dividend Reminder: Avista, Johnson & Johnson and Labcorp Holdings
NASDAQ · 2d ago
Evercore ISI Sticks to Their Hold Rating for Laboratory (LH)
TipRanks · 2d ago
Three Days Left To Buy Labcorp Holdings Inc. (NYSE:LH) Before The Ex-Dividend Date
Simply Wall St · 2d ago
Labcorp Positioned for Growth: Buy Rating Affirmed Amid Strategic Initiatives and Leadership Transition
TipRanks · 3d ago
Analysts Conflicted on These Healthcare Names: Laboratory (LH) and Medtronic (MDT)
TipRanks · 4d ago
Barclays Sticks to Their Hold Rating for Laboratory (LH)
TipRanks · 4d ago
Overweight-rated companies that are focused on ‘operational efficiency’ – MS
Seeking Alpha · 4d ago
Labcorp gets new finance chief
Seeking Alpha · 5d ago
Labcorp Announces New CFO Amid Leadership Transition
TipRanks · 5d ago
Labcorp Names Julia Wang Finance Chief as Glenn Eisenberg Retires
Dow Jones · 5d ago
Labcorp CFO Glenn Eisenberg To Retire; Julia Wang To Succeed
NASDAQ · 5d ago
*Labcorp Holdings Names Julia Wang Chief Financial Officer, Effective Dec. 2 >LH
Dow Jones · 5d ago
Labcorp CFO Glenn Eisenberg to retire, Julia Wang to succeed
TipRanks · 5d ago
*Labcorp CFO Glenn Eisenberg Announces Plans To Retire >LH
Dow Jones · 5d ago
Press Release: Labcorp CFO Glenn Eisenberg Announces Plans to Retire
Dow Jones · 5d ago
Surprising Analyst 12-Month Target For USCL
NASDAQ · 6d ago
Weekly Report: what happened at LH last week (1111-1115)?
Weekly Report · 6d ago
Is Labcorp Stock a Good Pick for Your Portfolio Right Now?
NASDAQ · 11/15 12:34
Labcorp Adds New Capabilities to Global Trial Connect: Stock to Gain?
NASDAQ · 11/13 13:21
More
Webull provides a variety of real-time LH stock news. You can receive the latest news about Labcorp Holdings Inc through multiple platforms. This information may help you make smarter investment decisions.
About LH
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and advanced science to improve health and improve lives through its unparalleled diagnostics and drug development laboratory capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is also focused on clinical diagnostics and reproductive and women's health in the United States outside of New York and New Jersey.